Summit Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Summit Financial's NVS Position: Q1 2026 in Review
Summit Financial increased its Novartis (NVS) stake by 19% in Q1 2026, buying an estimated $130K and bringing the position to 5,353 shares worth $818K. The position accounts for 0.01% of the portfolio, ranked #842.
Summit Financial first reported a position in NVS in Q2 2021 and has held it in 20 quarters since. The position peaked at $883K in Q1 2022. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Summit Financial held 5,353 shares of Novartis worth $818K as of Q1 2026.
- Summit Financial bought 846 Novartis shares in Q1 2026, an estimated $130K.
- Novartis made up 0.01% of Summit Financial's portfolio in Q1 2026, its #842 holding.
- Summit Financial first reported a position in Novartis in Q2 2021 and has held it in 20 quarters since.
- Summit Financial's Novartis position peaked at $883K in Q1 2022.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.